Insufficient scRNA-seq data for expression of ASMT at single-cell level.
Insufficient scRNA-seq data for expression of ASMT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 98% | 31.52 | 252 / 258 | 23% | 0.90 | 54 / 230 |
uterus | 99% | 31.90 | 168 / 170 | 1% | 0.02 | 4 / 459 |
spleen | 99% | 28.07 | 238 / 241 | 0% | 0 | 0 / 0 |
thymus | 98% | 28.11 | 639 / 653 | 1% | 0.01 | 5 / 605 |
prostate | 98% | 26.42 | 240 / 245 | 0% | 0.00 | 1 / 502 |
breast | 93% | 20.93 | 429 / 459 | 4% | 0.24 | 46 / 1118 |
ovary | 94% | 17.29 | 170 / 180 | 2% | 0.03 | 7 / 430 |
kidney | 94% | 13.29 | 84 / 89 | 1% | 0.02 | 13 / 901 |
blood vessel | 95% | 18.24 | 1271 / 1335 | 0% | 0 | 0 / 0 |
lung | 93% | 15.60 | 535 / 578 | 2% | 0.08 | 26 / 1155 |
intestine | 93% | 18.74 | 894 / 966 | 2% | 0.03 | 11 / 527 |
stomach | 89% | 13.56 | 319 / 359 | 6% | 0.20 | 16 / 286 |
adipose | 92% | 16.12 | 1109 / 1204 | 0% | 0 | 0 / 0 |
bladder | 90% | 21.90 | 19 / 21 | 2% | 0.03 | 8 / 504 |
esophagus | 86% | 14.95 | 1249 / 1445 | 2% | 0.04 | 4 / 183 |
brain | 86% | 14.46 | 2281 / 2642 | 1% | 0.22 | 7 / 705 |
peripheral blood | 86% | 22.30 | 801 / 929 | 0% | 0 | 0 / 0 |
skin | 82% | 13.47 | 1483 / 1809 | 3% | 0.04 | 14 / 472 |
pancreas | 81% | 10.13 | 266 / 328 | 1% | 0.02 | 2 / 178 |
lymph node | 0% | 0 | 0 / 0 | 79% | 7.06 | 23 / 29 |
liver | 69% | 7.51 | 155 / 226 | 1% | 0.01 | 3 / 406 |
heart | 69% | 8.04 | 596 / 861 | 0% | 0 | 0 / 0 |
muscle | 47% | 3.71 | 378 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.24 | 12 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.37 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006412 | Biological process | translation |
GO_0046219 | Biological process | indolalkylamine biosynthetic process |
GO_0006629 | Biological process | lipid metabolic process |
GO_0030187 | Biological process | melatonin biosynthetic process |
GO_0032259 | Biological process | methylation |
GO_0005829 | Cellular component | cytosol |
GO_0008171 | Molecular function | O-methyltransferase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008172 | Molecular function | S-methyltransferase activity |
GO_0017096 | Molecular function | acetylserotonin O-methyltransferase activity |
GO_0042802 | Molecular function | identical protein binding |
Gene name | ASMT |
Protein name | Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) Acetylserotonin O-methyltransferase Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) (HIOMT) |
Synonyms | |
Description | FUNCTION: [Isoform 1]: Catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine). .; FUNCTION: [Isoform 2]: Does not show Acetylserotonin O-methyltransferase activity. .; FUNCTION: [Isoform 3]: Does not show Acetylserotonin O-methyltransferase activity. . FUNCTION: Catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine). . FUNCTION: Catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine). . FUNCTION: Catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5-methoxytryptamine). . |
Accessions | P46597 ENST00000381241.9 [P46597-3] X5D311 ENST00000711209.1 [P46597-1] ENST00000711206.1 ENST00000381229.9 [P46597-1] ENST00000711210.1 [P46597-3] X5D784 I7HFW6 ENST00000432523.6 X5D2A4 ENST00000711208.1 [P46597-2] ENST00000381233.8 [P46597-2] |